Literature DB >> 28597066

Effects of Fat Grafting Containing Stem Cells in Microstomia and Microcheilia Derived from Systemic Sclerosis.

Oskar Blezien1, Francesco D'Andrea2, Giovanni Francesco Nicoletti3, Giuseppe Andrea Ferraro3.   

Abstract

BACKGROUND: Systemic sclerosis (SSc) is an autoimmune disease with multisystem involvement, dominated by a general fibrosis. The early stage of the disease is associated with progressive damage to microcirculation, particularly in the respiratory tract, the gastrointestinal tract and skin. The face assumes a typical appearance characterized by microstomia (reduction of mouth opening) and microcheilia (thinning of the lips). These conditions cause a considerable reduction in performance status of patients. We treated them by fat grafting, rich in adipose stem cells, and we evaluated through time clinical, functional and aesthetic evaluation of oral pathology associated with SSc. MATERIALS AND
METHOD: From September 2014 to May 2016, we enrolled and treated seven patients in the plastic, reconstructive and aesthetic surgery clinic. Through time, we evaluated the following parameters: evaluation of mouth opening (maximum opening in superior-inferior and lateral directions) and lip thicknesses, both measured by doctors of the aforementioned operating unit; variation in the quality of life as perceived by patients according to the MHISS scale (Mouth Handicap Systemic Sclerosis); variation in severity of labial fibrosis assessed by microscopic analysis of pre- and post-fat transfer samples in the pathology clinic; safety of the protocol, according to the management of side effects resulting from the procedure; aesthetic evaluation, made by external observers and non-experts in the field, on pre- and post-operative photographs. RESULTS AND
CONCLUSIONS: We reported satisfying results, both functionally and aesthetically, for all parameters except one, for which the sample size might have proven critical. These data should be a starting point for further experimental research and clinical trials. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Entities:  

Keywords:  Adipose stem cells; Fat grafting; Lips; Microcheilia; Microstomia; Mouth; Oral pathology; Systemic sclerosis

Mesh:

Year:  2017        PMID: 28597066     DOI: 10.1007/s00266-017-0904-1

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN: 0364-216X            Impact factor:   2.326


  6 in total

1.  Autologous Fat Grafting in the Treatment of Facial Scleroderma.

Authors:  Mehdi Gheisari; Arman Ahmadzadeh; Nilofar Nobari; Behzad Iranmanesh; Nikoo Mozafari
Journal:  Dermatol Res Pract       Date:  2018-08-01

2.  Fat Grafting Subjectively Improves Facial Skin Elasticity and Hand Function of Scleroderma Patients.

Authors:  Amy L Strong; Widya Adidharma; Owen H Brown; Paul S Cederna
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-01-25

Review 3.  Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis.

Authors:  Irene Rosa; Eloisa Romano; Bianca Saveria Fioretto; Marco Matucci-Cerinic; Mirko Manetti
Journal:  World J Stem Cells       Date:  2021-01-26       Impact factor: 5.326

4.  Efficacy and safety of mesenchymal stem cells in the treatment of systemic sclerosis: a systematic review and meta-analysis.

Authors:  Jiehan Cui; Lu Jin; Meng Ding; Jingjing He; Lin Yang; Shaoxin Cui; Xiaoping Wang; Jun Ma; Aijing Liu
Journal:  Stem Cell Res Ther       Date:  2022-03-21       Impact factor: 6.832

5.  Oro-facial fibrosis in systemic sclerosis: a reconstructive journey.

Authors:  Faith Hyun Kyung Jeon; Michelle Griffin; Jajini Varghese; Peter Edward Michael Butler
Journal:  BMJ Case Rep       Date:  2020-10-10

6.  Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: a prospective open-label study.

Authors:  Roberto Pirrello; Barbara Verro; Giulia Grasso; Piero Ruscitti; Adriana Cordova; Roberto Giacomelli; Francesco Ciccia; Giuliana Guggino
Journal:  Arthritis Res Ther       Date:  2019-12-13       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.